Search Results for: YIF1A

83 interactions involving YIF1A - Yip1 interacting factor homolog A, membrane trafficking protein found:

Sort by: Symbol Number of Pathways Number of Drugs Number of Diseases
Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
Novel ADAM17 ADAM metallopeptidase domain 17
  • Nuclear signaling by ERBB4
  • Collagen degradation
  • Signaling by EGFR
  • Regulated proteolysis of p75NTR
  • Activated NOTCH1 Transmits Signal to the Nucleus
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • Constitutive Signaling by NOTCH1 HD Domain Mutants
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • Release of Hh-Np from the secreting cell
  • TNF signaling
  • CD163 mediating an anti-inflammatory response
  • Growth hormone receptor signaling
  • (3S)-1-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}pyrrolidine-3-thiol
  • 3-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}propane-1-thiol
  • 4-({4-[(4-AMINOBUT-2-YNYL)OXY]PHENYL}SULFONYL)-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE
  • (2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE
  • methyl (1R,2S)-2-(hydroxycarbamoyl)-1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate
  • (1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid
  • N-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}-5-methyl-D-tryptophan
  • (3S)-4-{[4-(BUT-2-YNYLOXY)PHENYL]SULFONYL}-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE
Novel GNL1 G protein nucleolar 1 (putative)
Novel HEATR1 HEAT repeat containing 1
  • rRNA modification in the nucleus and cytosol
  • Major pathway of rRNA processing in the nucleolus and cytosol
Novel KAT5 lysine acetyltransferase 5
  • Formation of the beta-catenin:TCF transactivating complex
  • Formation of the beta-catenin:TCF transactivating complex
  • DNA Damage/Telomere Stress Induced Senescence
  • HATs acetylate histones
  • HDR through Single Strand Annealing (SSA)
  • HDR through Homologous Recombination (HRR)
  • Sensing of DNA Double Strand Breaks
  • Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)
  • Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
  • Resolution of D-loop Structures through Holliday Junction Intermediates
  • Nonhomologous End-Joining (NHEJ)
  • Homologous DNA Pairing and Strand Exchange
  • Processing of DNA double-strand break ends
  • Presynaptic phase of homologous DNA pairing and strand exchange
  • Regulation of TP53 Activity through Phosphorylation
  • G2/M DNA damage checkpoint
  • Estrogen-dependent gene expression
  • Coenzyme A
  • S-Acetyl-Cysteine
Novel KCNK5 potassium two pore domain channel subfamily K member 5
  • Phase 4 - resting membrane potential
Novel MRPL18 mitochondrial ribosomal protein L18
  • Mitochondrial translation initiation
  • Mitochondrial translation elongation
  • Mitochondrial translation elongation
  • Mitochondrial translation termination
Novel PRIM1 DNA primase subunit 1
  • Inhibition of replication initiation of damaged DNA by RB1/E2F1
  • Polymerase switching on the C-strand of the telomere
  • Telomere C-strand synthesis initiation
  • DNA replication initiation
  • Activation of the pre-replicative complex
  • Polymerase switching
  • Removal of the Flap Intermediate
  • Processive synthesis on the lagging strand
Novel SLCO2B1 solute carrier organic anion transporter family member 2B1
  • Transport of organic anions
  • Gemfibrozil
  • Telaprevir
Novel STARD10 StAR related lipid transfer domain containing 10
  • Synthesis of PC
Novel STIP1 stress induced phosphoprotein 1
  • HSP90 chaperone cycle for steroid hormone receptors (SHR)
  • Copper
Novel WDR74 WD repeat domain 74
APOA5 apolipoprotein A5
  • PPARA activates gene expression
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • Post-translational protein phosphorylation
  • Assembly of active LPL and LIPC lipase complexes
  • Chylomicron remodeling
  • Hyperlipoproteinemia, type V
AQP6 aquaporin 6
  • Passive transport by Aquaporins
BNIP2 BCL2 interacting protein 2
  • Myogenesis
  • Myogenesis
C4orf3 chromosome 4 open reading frame 3
CD79A CD79a molecule
  • CD22 mediated BCR regulation
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Agammaglobulinemias, including the following six diseases: X-linked agammaglobulinemia (Bruton's agammaglobulinemia, XLA); IgM heavy chain gene deletions; Ig-alpha defect; Autosomal recessive agammaglobulinaemia; B cell-linker protein (BLNK) deficiency; Leucine-rich repeat-containing 8
CDK2AP2 cyclin dependent kinase 2 associated protein 2
CERS2 ceramide synthase 2
  • Sphingolipid de novo biosynthesis
CNRIP1 cannabinoid receptor interacting protein 1
CST6 cystatin E/M

Page 1 out of 5 pages